Trova

Targeting Acute Myelogenous Leukemia Using Potent Human

4.7 (596) · € 26.99 · In Magazzino

Targeting Acute Myelogenous Leukemia Using Potent Human
Cancers, Free Full-Text

Cancers, Free Full-Text

Cancers, Free Full-Text

Cancers, Free Full-Text

Emerging Immunotherapies in Acute Myeloid Leukemia Offer Hope in a  Difficult Disease

Emerging Immunotherapies in Acute Myeloid Leukemia Offer Hope in a Difficult Disease

The genesis and evolution of acute myeloid leukemia stem cells in the  microenvironment: From biology to therapeutic targeting

The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting

Targeting multiple signaling pathways: the new approach to acute myeloid  leukemia therapy

Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy

Advances in acute myeloid leukemia differentiation therapy: A critical  review - ScienceDirect

Advances in acute myeloid leukemia differentiation therapy: A critical review - ScienceDirect

What Is Acute Myeloid Leukemia (AML)? Symptoms, Causes, Diagnosis,  Treatment, and Prevention

What Is Acute Myeloid Leukemia (AML)? Symptoms, Causes, Diagnosis, Treatment, and Prevention

Improving outcomes in chronic myeloid leukemia through harnessing the  immunological landscape

Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape

Targeting mitochondrial respiration for the treatment of acute myeloid  leukemia - ScienceDirect

Targeting mitochondrial respiration for the treatment of acute myeloid leukemia - ScienceDirect

Emerging treatments in acute myeloid leukemia: current standards and unmet  challenges.

Emerging treatments in acute myeloid leukemia: current standards and unmet challenges.

Possible treatment algorithm in relapsed/refractory AML patients. AML =

Possible treatment algorithm in relapsed/refractory AML patients. AML =

Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK  Cells Modified with an Improved SB Transposon System: Molecular Therapy

Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System: Molecular Therapy

Cancers, Free Full-Text

Cancers, Free Full-Text

Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic  targets - ScienceDirect

Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targets - ScienceDirect